Back

Perioperative empagliflozin and risk of acute kidney injury after cardiac surgery: a systematic review and meta-analysis

31 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Cardiotoxicity of drugs: machine learning and aortic stenosis Diuretics ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Gabriel Almeida Alves

(Brazil)

4 More presentations in this session

Presentation thumbnail
Targeting cardiac remodeling and sirtuin gene expression in type 1 diabetes mellitus: role of dapagliflozin
Mrs G. Brandao (Botucatu, BR)
Abstract
Presentation thumbnail
Semaglutide attenuates diabetic vascular calcification by enhancing autophagy and lysosomal function via targeting CPNE1
Doctor S. Xiao (Nanjing, CN)
Abstract
Presentation thumbnail
GLP-1 receptor agonist reduces anthracycline– and trastuzumab–induced cardiac dysfunction and systemic hs-CRP, IL-1β and IL-6 in non-diabetic preclinical models
Doctor N. Maurea (Naples, IT)
Abstract
Presentation thumbnail
Effects of dapagliflozin administration under sustained arterial hypertension
Miss A. Santos (Botucatu, BR)
Abstract

Access the full session

Session thumbnail
Cardiotoxicity of drugs: machine learning and aortic stenosis

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients
29 June 2021
thumbnail
Congress Presentation
The impact of intraoperative hemoadsorption on acute kidney injury and renal replacement therapy in cardiovascular surgery: a systematic review and meta-analysis.
1 September 2025
thumbnail
Congress Presentation
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results
29 June 2021
thumbnail
Congress Session
Salt and renin angiotensin aldosterone system in hypertension
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources